Evgen Pharma PLC (LSE:EVG) - Share price


Stock Report

Evgen Pharma PLC EVG

Last Price
GBX17.54

Day Change
-0.21|-1.18%

As of 19/07/2019
11:56:10 BST | GBX
Minimum 15 Minutes Delay.

Last Close17.75p
Day Range17.50 - 17.55
Mkt Cap23.54Mil
52-Wk Range13.25 - 33.00
Yield %-
ISINGB00BSVYN304
Volume28,377
P/E-6.40
P/S-
P/CF-0.07

Share Price

Total Returns 18/07/2019

 Chg (%)  
More ...
Evgen Pharma PLC-6.58 
FTSE 100 TR GBP0.81
 
Financials
201720182019
More ...
Income Statement
Turnover---
Operating Profit-3.66-3.03-3.12
Net Profit-3.07-2.58-2.62
Reported EPS-4.19-3.28-2.74
Balance Sheet
Current Assets4.604.142.66
Non Current Assets0.140.130.10
Total Assets4.744.262.76
Current Liabilities0.510.390.69
Total Liabilities---
Total Equity4.233.872.08
Cash Flow
Operating Cash Flow-3.22-3.01-2.72
Net Change in Cash-1.26-0.23-1.59

Regulatory News

DateAuthor Headline
08/02/2016Karen Kwok What Stocks Are the Top Fund Managers Buying?
Admist the market volatility savvy investors are looking for bargain stocks. But which stocks and sectors are the professionals snapping up and which equities are they dumping?

Company Profile

Evgen Pharma PLC is a clinical stage drug development company focused on cancer and neurological disease. Its pipeline is based on Sulforadex technology which includes synthetic and stabilized analogues of sulforaphane.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE AIM All-Share

Next Event 12/12/2019

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-150.29
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorDr. Susan Elizabeth Foden
Executive Director, Chief Executive OfficerDr. Stephen Joseph Franklin
Executive Director, Chief Financial OfficerRichard Anthony Moulson BSc,FCA
Executive Director, ChairmanBarry Clare
Non-Executive DirectorDr. Alan John Barge
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.